Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study
Abstract As a specific predictor of ovarian reserve, serum anti-Müllerian hormone (AMH) has become an area of intense research interest in the field of assisted reproductive technology. We assessed the relationship between AMH levels and pregnancy outcomes in Chinese patients and investigate the inf...
Main Authors: | Yanru Hou, Lu Wang, Yian Li, Jiajia Ai, Li Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-28724-8 |
Similar Items
-
Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
by: Kristof Chwalisz, M.D., Ph.D.
Published: (2023-06-01) -
The use of gonadotropin-releasing hormone antagonist in women undergoing intrauterine insemination
by: M Yousef Elsemary, et al.
Published: (2019-01-01) -
Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?
by: Anna Maria Rzewuska, et al.
Published: (2023-01-01) -
The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
by: Shen Zhao, et al.
Published: (2023-01-01) -
Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
by: Wignall Jacqui, et al.
Published: (2010-04-01)